Medicines containing 5-fluorouracil (i.v.) - In patients with moderate to severe renal impairment, interpret DPD deficiency phenotyping (via blood uracil levels) with caution
24/10/2024
Medicines for human use
Direct healthcare professional communication (DHPC)
Important Safety Information from Accord Healthcare Ireland Ltd. and Pfizer Healthcare Ireland regarding Medicines containing 5-fluorouracil (i.v.): In patients with moderate or severe renal impairment, phenotyping for dihydropyrimidine dehydrogenase (DPD) deficiency by measuring blood uracil levels should be interpreted with caution